Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 4, 2024
Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutationHaruka Mori, Dongzhu Xu, Yuzuno Shimoda, et al.
Life Sciences|July 16, 2022
Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasetsZixun Yuan, Nobuyuki Murakoshi, Dongzhu Xu, et al.
Cell Death Discovery|May 23, 2026
A kidney-protective mechanism via cellular oxidative stress reduction induced by CD5L proteinKai Kudo, Takashi Ikeda, Kazutaka Ikeda, et al.
Frontiers in Cardiovascular Medicine|February 6, 2023
Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathyYoshiko Murakata, Fumi Yamagami, Nobuyuki Murakoshi, et al.
International Journal of Molecular Sciences|January 16, 2021
Neutrophil Elastase Deficiency Ameliorates Myocardial Injury Post Myocardial Infarction in MiceYukino Ogura, Kazuko Tajiri, Nobuyuki Murakoshi, et al.
Oncology Letters|July 18, 2024
Co‑expression of <i>SLC20A1</i> and <i>ALDH1A3</i> is associated with poor prognosis, and <i>SLC20A1</i> is required for the survival of ALDH1‑positive pancreatic cancer stem cellsIzumi Matsuoka, Takahiro Kasai, Chotaro Onaga, et al.
International Journal of Molecular Sciences|February 12, 2021
Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in MiceSiqi Li, Kazuko Tajiri, Nobuyuki Murakoshi, et al.
Clinical Science (London, England : 1979)|August 13, 2021
Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive ratsDongZhu Xu, Nobuyuki Murakoshi, Kazuko Tajiri, et al.
Cell Reports. Medicine|October 10, 2025
Super-adjuvant nanoparticles for platform cancer vaccinationGriffin I Kane, Tiana E Naylor, Ellis F Lusi, et al.
Molecular Cancer Therapeutics|March 26, 2026
Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk NeuroblastomaGriffin I Kane, Miranda B Diaz-Infante, Kim Wigglesworth, et al.
Pageof 3